Japanese Guideline for Adult Asthma 2014.
暂无分享,去创建一个
K. Ohta | M. Adachi | K. Akiyama | K. Yamauchi | M. Ichinose | Y. Tohda | H. Sugiura | H. Nagase | M. Yamaguchi
[1] C. Perret,et al. Mechanical Controlled Hypoventilation in Status Asthmaticus1,2 , 2015 .
[2] R. Severson,et al. The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population. , 2012, The Journal of allergy and clinical immunology.
[3] S. Anderson,et al. Respiratory health of elite athletes – preventing airway injury: a critical review , 2012, British Journal of Sports Medicine.
[4] M. Miravitlles,et al. Fenotipos clínicos de la EPOC. Identificación, definición e implicaciones para las guías de tratamiento , 2012 .
[5] M. Miravitlles,et al. Clinical Phenotypes of COPD: Identication, Denition and Implications for Guidelines , 2012 .
[6] J. Bousquet,et al. Prevalence and impact of rhinitis in asthma. SACRA, a cross‐sectional nation‐wide study in Japan , 2011, Allergy.
[7] Nicola A Hanania,et al. Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.
[8] Margaret W Leigh,et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.
[9] D. Price,et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. , 2011, The New England journal of medicine.
[10] L. Mouthon,et al. The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort , 2011, Medicine.
[11] E. R. Sutherland,et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. , 2010, The New England journal of medicine.
[12] N. Higashi,et al. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers. , 2010, The Journal of allergy and clinical immunology.
[13] S. Salpeter,et al. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. , 2010, The American journal of medicine.
[14] Christine Jenkins,et al. Overall asthma control: the relationship between current control and future risk. , 2010, The Journal of allergy and clinical immunology.
[15] K. Ohta,et al. Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. , 2010, Allergology international : official journal of the Japanese Society of Allergology.
[16] Parameswaran Nair,et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.
[17] Ana Sousa,et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.
[18] S. Bibby,et al. Leukotriene receptor antagonist therapy and Churg–Strauss syndrome: culprit or innocent bystander? , 2008, Thorax.
[19] K. Ohta,et al. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients. , 2008, Respiratory medicine.
[20] M. Olivieri,et al. Omalizumab in persistent severe bakers’ asthma , 2008, Allergy.
[21] I. Pavord,et al. Prevalence, pathogenesis, and causes of chronic cough , 2008, The Lancet.
[22] B. Löwe,et al. Depression and panic disorder as predictors of health outcomes for patients with asthma in primary care. , 2008, Respiratory medicine.
[23] M. Ichinose,et al. Peak expiratory flow variability adjusted by forced expiratory volume in one second is a good index for airway responsiveness in asthmatics. , 2008, Internal medicine.
[24] J. Bousquet,et al. Predicting and evaluating response to omalizumab in patients with severe allergic asthma. , 2007, Respiratory medicine.
[25] N. Anthonisen,et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. , 2007, The New England journal of medicine.
[26] S. Durham,et al. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. , 2007, The Journal of allergy and clinical immunology.
[27] H. Derendorf,et al. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma , 2006, European Respiratory Journal.
[28] D. Stevenson,et al. Clinical and pathologic perspectives on aspirin sensitivity and asthma. , 2006, The Journal of allergy and clinical immunology.
[29] D. Price,et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial , 2006, Allergy.
[30] N. Suttorp,et al. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. , 2006, The Journal of allergy and clinical immunology.
[31] Linda Abetz,et al. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.
[32] L. Boulet,et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations , 2006, European Respiratory Journal.
[33] T. Shimoda,et al. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids. , 2005, Allergy and asthma proceedings.
[34] J. Cowan,et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.
[35] M. Fujimura,et al. Importance of atopic cough, cough variant asthma and sinobronchial syndrome as causes of chronic cough in the Hokuriku area of Japan , 2005, Respirology.
[36] J Bousquet,et al. Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE , 2005, Allergy.
[37] W. Busse. NAEPP Expert Panel Report: Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment—2004 Update , 2005 .
[38] T. Miyamoto,et al. Effect of Transdermal Tulobuterol Added to Inhaled Corticosteroids in Asthma Patients , 2005 .
[39] R. Pauwels,et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.
[40] Stephen T Holgate,et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. , 2004, American journal of respiratory and critical care medicine.
[41] Junpei Saito,et al. Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren. , 2004, The Journal of allergy and clinical immunology.
[42] Philip Marcus,et al. Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.
[43] N. Thomson,et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. , 2003, American journal of respiratory and critical care medicine.
[44] H. Bisgaard,et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial , 2003, BMJ : British Medical Journal.
[45] Joan B Soriano,et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.
[46] K. Ohta,et al. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma. , 2003, The Journal of allergy and clinical immunology.
[47] E. Norjavaara,et al. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide. , 2003, The Journal of allergy and clinical immunology.
[48] I. Shpirer,et al. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. , 2003, Chest.
[49] William W Busse,et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial , 2003, The Lancet.
[50] L. Edwards,et al. Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily , 2003 .
[51] I. Pavord,et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.
[52] J. Tunon-de-lara,et al. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. , 2002, American journal of respiratory and critical care medicine.
[53] S. Spector,et al. Exercise-induced asthma: diagnosis and management. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[54] H. Taniguchi,et al. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[55] I. Adcock,et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[56] A. Fuhlbrigge,et al. Intranasal steroids and the risk of emergency department visits for asthma. , 2002, The Journal of allergy and clinical immunology.
[57] M. Adachi,et al. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. , 2002, Chest.
[58] Stephen C Lazarus,et al. Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .
[59] J. Bousquet,et al. Sputum eosinophilia in Churg-Strauss syndrome. , 2001, Respiratory medicine.
[60] E. Israel,et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. , 2001, JAMA.
[61] T. Bengtsson,et al. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma. , 2001, American journal of respiratory and critical care medicine.
[62] M. Abramson,et al. Corticosteroids for acute severe asthma in hospitalised patients. , 2001, The Cochrane database of systematic reviews.
[63] E. Kerwin,et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. , 2000, The Journal of allergy and clinical immunology.
[64] A. Szczeklik,et al. Natural history of aspirin‐induced asthma , 2000 .
[65] E. Tagaya,et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study , 2000, The Lancet.
[66] S. Kobayashi,et al. [Asthma death among adults in Japan 1995-1997. Analysis of 295 cases reported questionnaires sent to hospitals with more than 100 beds. Asthma Death Investigation Committee]. , 2000, Arerugi = [Allergy].
[67] K. Shirato,et al. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. , 2000, The European respiratory journal.
[68] P. O'Byrne,et al. Induced sputum cell counts in healthy adults. , 2000, American journal of respiratory and critical care medicine.
[69] H. Ogawa,et al. Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non‐productive cough , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[70] M. Adachi,et al. Effect of a leukotriene receptor antagonist, pranlukast hydrate, on airway inflammation and airway hyperresponsiveness in patients with moderate to severe asthma , 2000 .
[71] G. Guyatt,et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. , 1999, The European respiratory journal.
[72] B. Lipworth. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.
[73] J. Smyth,et al. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. , 1999, JAMA.
[74] I. Matsumoto,et al. [Change in prevalence of allergic diseases in primary school children in Fukuoka City for the last fifteen years]. , 1999, Arerugi = [Allergy].
[75] J. Vandenbroucke,et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.
[76] E. Israel,et al. Correction: Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. , 1999, The New England journal of medicine.
[77] J. Fujita,et al. Comparison between fenoterol and fenoterol plus oxitropium bromide delivered by metered-dose inhaler with InspirEase to relieve acute asthma attack. , 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.
[78] M. Adachi,et al. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. , 1998, The Journal of allergy and clinical immunology.
[79] F. Ducharme,et al. Should inhaled anticholinergics be added to β2 agonists for treating acute childhood and adolescent asthma? A systematic review , 1998, BMJ.
[80] S. Vedal,et al. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. , 1998, American journal of respiratory and critical care medicine.
[81] W. Busse,et al. Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.
[82] R. Falk,et al. Small-vessel vasculitis. , 1997, The New England journal of medicine.
[83] K. Chung,et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. , 1997, The New England journal of medicine.
[84] D. Postma,et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.
[85] M. Kondo,et al. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. , 1997, American journal of respiratory and critical care medicine.
[86] Y. Nakamura,et al. The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. , 1997, The European respiratory journal.
[87] D. Schroeder,et al. Perioperative Respiratory Complications in Patients with Asthma , 1996, Anesthesiology.
[88] K. Ohta,et al. The prolonged survival of human eosinophils with interleukin‐5 and its inhibition by theophylline via apoptosis 1 , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[89] K. Ohta,et al. Aminophlline is effective on acute exacerbations of asthma in adults–objective improvements in peak flow, spirogram, arterial blood gas measurements and lung sounds , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[90] Deborah Jarvis,et al. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). , 1996, The European respiratory journal.
[91] R. Simon,et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. , 1995, The Journal of allergy and clinical immunology.
[92] P. Barnes,et al. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. , 1995, The Journal of clinical investigation.
[93] C. Salome,et al. Which index of peak expiratory flow is most useful in the management of stable asthma? , 1995, American journal of respiratory and critical care medicine.
[94] T. Haahtela,et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.
[95] J. Richter,et al. Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology. , 1994, Chest.
[96] P. Ind,et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid , 1994, The Lancet.
[97] L. Prieto,et al. Modification of concentration-response curves to inhaled methacholine after the pollen season in subjects with pollen induced rhinitis. , 1994, Thorax.
[98] C. Page,et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.
[99] C. Pickering,et al. Double-blind trial of steroid tapering in acute asthma , 1993, The Lancet.
[100] F. Simons,et al. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. , 1993, The Journal of allergy and clinical immunology.
[101] T. Fukuda,et al. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. , 1992, The American review of respiratory disease.
[102] G. Russell,et al. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. , 1992, BMJ.
[103] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[104] R. Schleimer. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. , 1990, The American review of respiratory disease.
[105] P. Greenberger. Asthma during pregnancy. , 1990, The Journal of asthma : official journal of the Association for the Care of Asthma.
[106] P. Burney,et al. The distribution of peak expiratory flow variability in a population sample. , 1989, The American review of respiratory disease.
[107] S. Holgate,et al. SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.
[108] S. Holgate,et al. A self management plan in the treatment of adult asthma. , 1989, Thorax.
[109] M. Schatz,et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. , 1988, The Journal of allergy and clinical immunology.
[110] G. Mchardy,et al. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. , 1987, Thorax.
[111] E. Nizankowska,et al. Hydrocortisone and airflow impairment in aspirin-induced asthma. , 1985, The Journal of allergy and clinical immunology.
[112] Lewis J Smith,et al. 113 Bronchoalveolar lavage in allergic bronchopulmonary aspergillosis (ABPA) , 1985 .
[113] T. Fukuda,et al. [Clinical evaluation of standard method of acetylcholine inhalation test in bronchial asthma]. , 1984, Arerugi = [Allergy].
[114] Satoshi Suzuki,et al. Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application. , 1981, Chest.
[115] D. Pavia,et al. Deposition of pressurized suspension aerosols inhaled through extension devices. , 1981, The American review of respiratory disease.
[116] B. Cooper,et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. , 1977, Annals of internal medicine.
[117] A. Cats,et al. HL-A 27 AND ANKYLOSING SPONDYLITIS , 1975, The Lancet.
[118] J. Wyatt,et al. Chronic Bronchitis, Asthma, and Pulmonary Emphysema , 1962 .